Journal
STROKE
Volume 53, Issue 9, Pages 2847-2858Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.121.038349
Keywords
chemokines; cryptogenic stroke; inflammation; interleukin; ischemic stroke; proteomics
Categories
Funding
- Swedish Heart and Lung Foundation [20190203]
- Swedish Research Council [2021-01114]
- Swedish government [ALFGBG-720081]
- King Gustaf V:s and Queen Victorias Freemason's Foundation
- Rune and Ulla Amlovs Foundation
- John and Brit Wennerstrom Foundation
- Per-Olof Ahl Foundation
- Gothenburg Foundation for Neurological Research
- Swedish Research Council [2021-01114] Funding Source: Swedish Research Council
Ask authors/readers for more resources
This study profiles inflammation-related plasma proteins in ischemic stroke patients and controls, finding differentially regulated proteins during the acute-phase and later time points. These proteins may be involved in the pathogenesis and inflammatory processes of stroke.
Background: Inflammation contributes both to the pathogenesis of stroke and the response to brain injury. We aimed to identify proteins reflecting the acute-phase response and proteins more likely to reflect proinflammatory processes present before stroke by broadly profiling inflammation-related plasma proteins in a longitudinal ischemic stroke study. Methods: Participants were from a Swedish ischemic stroke cohort (SAHLSIS [Sahlgrenska Academy Study on Ischemic Stroke], n=600 cases and n=600 controls). Plasma levels of 65 proteins including chemokines, interleukins, surface molecules, and immune receptors were measured once in controls and at 3x in cases: during the acute phase, after 3 months, and for a subgroup (n=223) at 7-year follow-up. Associations between proteins and ischemic stroke or subtype were investigated in multivariable binary regression models corrected for age, sex, vascular risk factors, and multiple testing. Results: In the acute phase, 48 proteins were significantly and independently associated with ischemic stroke (false discovery rate adjusted P<0.05). At 3-month follow-up, 51 proteins and at 7-year follow-up 50 proteins were associated with ischemic stroke. The majority of proteins were upregulated in cases compared with controls (n=34 at all time points) and the most upregulated were CXCL5 (CXC chemokine ligand 5) and OSM (oncostatin M). Generally, large artery and cardioembolic stroke had the highest protein levels. However, several interesting subtype-specific differences were also detected at each time point. Conclusions: We found inflammation-related proteins that were differentially regulated in ischemic stroke cases compared with controls only in the acute phase and others that remained elevated also at later time points. This latter group of proteins could reflect underlying pathophysiological processes of relevance. Future studies both in terms of disease risk and prognostication are warranted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available